Global Cystic Fibrosis Therapeutics Market to Reach $46.8 Billion by 2030

ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, March 15, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cystic Fibrosis Therapeutics Industry" - https://www.reportlinker.com/p06346124/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Cystic Fibrosis Therapeutics Market to Reach $46.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Cystic Fibrosis Therapeutics estimated at US$15.4 Billion in the year 2022, is projected to reach a revised size of US$46.8 Billion by 2030, growing at aCAGR of 14.9% over the period 2022-2030. Medication, one of the segments analyzed in the report, is projected to record 15.3% CAGR and reach US$42.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Devices segment is readjusted to a revised 12.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.2 Billion, While China is Forecast to Grow at 21.2% CAGR

The Cystic Fibrosis Therapeutics market in the U.S. is estimated at US$4.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.1 Billion by the year 2030 trailing a CAGR of 21.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 12.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.

Select Competitors (Total 56 Featured)
- AbbVie Inc.
- Galapagos NV
- Genentech
- Gilead Sciences Inc.
- Novartis AG
- Vertex Pharmaceuticals Inc.


Read the full report: https://www.reportlinker.com/p06346124/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Cystic Fibrosis - A Prelude
Recent Market Activity
CF Disease Prevalence: A Brief Note
Treatment Modalities for Cystic Fibrosis
CFTR Modulators: Key Drug Category
Competitive Scenario
Vertex: At the Forefront of Cystic Fibrosis Therapeutics
Cystic Fibrosis \Therapeutics - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
AbbVie Inc. (USA)
Galapagos NV (Belgium)
Genentech, Inc. (USA)
Gilead Sciences, Inc. (USA)
Novartis AG (Switzerland)
Vertex Pharmaceuticals (USA)

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Cystic Fibrosis Therapeutics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Cystic Fibrosis
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Medication by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Medication by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Medication by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Devices by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 9: World 16-Year Perspective for Devices by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Other Treatment Methods by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Other Treatment Methods by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Other Treatment Methods
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Hospital by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Hospital by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Hospital by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Retail Pharmacies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Retail Pharmacies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Retail Pharmacies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Other Distribution Channels by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Other Distribution Channels
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Other Distribution
Channels by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 22: World Cystic Fibrosis Therapeutics Market Analysis of
Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
Cystic Fibrosis Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2023
(E)
Table 23: USA Recent Past, Current & Future Analysis for Cystic
Fibrosis Therapeutics by Treatment Method - Medication, Devices
and Other Treatment Methods - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 24: USA Historic Review for Cystic Fibrosis Therapeutics
by Treatment Method - Medication, Devices and Other Treatment
Methods Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 25: USA 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 26: USA Recent Past, Current & Future Analysis for Cystic
Fibrosis Therapeutics by Distribution Channel - Hospital,
Retail Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 27: USA Historic Review for Cystic Fibrosis Therapeutics
by Distribution Channel - Hospital, Retail Pharmacies and Other
Distribution Channels Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 28: USA 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

CANADA
Table 29: Canada Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 30: Canada Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 31: Canada 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 32: Canada Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 33: Canada Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 34: Canada 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

JAPAN
Cystic Fibrosis Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 35: Japan Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 36: Japan Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 37: Japan 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 38: Japan Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 39: Japan Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 40: Japan 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

CHINA
Cystic Fibrosis Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2023 (E)
Table 41: China Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 42: China Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 43: China 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 44: China Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 45: China Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 46: China 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

EUROPE
Cystic Fibrosis Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 47: Europe Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 48: Europe Historic Review for Cystic Fibrosis
Therapeutics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 49: Europe 16-Year Perspective for Cystic Fibrosis
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2014, 2023 & 2030

Table 50: Europe Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 51: Europe Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 52: Europe 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 53: Europe Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 54: Europe Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 55: Europe 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

FRANCE
Cystic Fibrosis Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2023 (E)
Table 56: France Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 57: France Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 58: France 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 59: France Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 60: France Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 61: France 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

GERMANY
Cystic Fibrosis Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 62: Germany Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 63: Germany Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 64: Germany 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 65: Germany Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 66: Germany Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 67: Germany 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

ITALY
Table 68: Italy Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 69: Italy Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 70: Italy 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 71: Italy Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 72: Italy Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 73: Italy 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

UNITED KINGDOM
Cystic Fibrosis Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2023
(E)
Table 74: UK Recent Past, Current & Future Analysis for Cystic
Fibrosis Therapeutics by Treatment Method - Medication, Devices
and Other Treatment Methods - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 75: UK Historic Review for Cystic Fibrosis Therapeutics
by Treatment Method - Medication, Devices and Other Treatment
Methods Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 76: UK 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 77: UK Recent Past, Current & Future Analysis for Cystic
Fibrosis Therapeutics by Distribution Channel - Hospital,
Retail Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 78: UK Historic Review for Cystic Fibrosis Therapeutics
by Distribution Channel - Hospital, Retail Pharmacies and Other
Distribution Channels Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 79: UK 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

SPAIN
Table 80: Spain Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 81: Spain Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 82: Spain 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 83: Spain Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 84: Spain Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 85: Spain 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

RUSSIA
Table 86: Russia Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 87: Russia Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 88: Russia 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 89: Russia Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 90: Russia Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 91: Russia 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

REST OF EUROPE
Table 92: Rest of Europe Recent Past, Current & Future Analysis
for Cystic Fibrosis Therapeutics by Treatment Method -
Medication, Devices and Other Treatment Methods - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 93: Rest of Europe Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 94: Rest of Europe 16-Year Perspective for Cystic
Fibrosis Therapeutics by Treatment Method - Percentage
Breakdown of Value Sales for Medication, Devices and Other
Treatment Methods for the Years 2014, 2023 & 2030

Table 95: Rest of Europe Recent Past, Current & Future Analysis
for Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 96: Rest of Europe Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 97: Rest of Europe 16-Year Perspective for Cystic
Fibrosis Therapeutics by Distribution Channel - Percentage
Breakdown of Value Sales for Hospital, Retail Pharmacies and
Other Distribution Channels for the Years 2014, 2023 & 2030

ASIA-PACIFIC
Cystic Fibrosis Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 98: Asia-Pacific Recent Past, Current & Future Analysis
for Cystic Fibrosis Therapeutics by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 99: Asia-Pacific Historic Review for Cystic Fibrosis
Therapeutics by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 100: Asia-Pacific 16-Year Perspective for Cystic Fibrosis
Therapeutics by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2014, 2023 & 2030

Table 101: Asia-Pacific Recent Past, Current & Future Analysis
for Cystic Fibrosis Therapeutics by Treatment Method -
Medication, Devices and Other Treatment Methods - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 102: Asia-Pacific Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 103: Asia-Pacific 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 104: Asia-Pacific Recent Past, Current & Future Analysis
for Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 105: Asia-Pacific Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 106: Asia-Pacific 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

AUSTRALIA
Cystic Fibrosis Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Australia for 2023 (E)
Table 107: Australia Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 108: Australia Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 109: Australia 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 110: Australia Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 111: Australia Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 112: Australia 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

INDIA
Cystic Fibrosis Therapeutics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in India for 2023 (E)
Table 113: India Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Treatment Method - Medication,
Devices and Other Treatment Methods - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 114: India Historic Review for Cystic Fibrosis
Therapeutics by Treatment Method - Medication, Devices and
Other Treatment Methods Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 115: India 16-Year Perspective for Cystic Fibrosis
Therapeutics by Treatment Method - Percentage Breakdown of
Value Sales for Medication, Devices and Other Treatment Methods
for the Years 2014, 2023 & 2030

Table 116: India Recent Past, Current & Future Analysis for
Cystic Fibrosis Therapeutics by Distribution Channel -
Hospital, Retail Pharmacies and Other Distribution Channels -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 117: India Historic Review for Cystic Fibrosis
Therapeutics by Distribution Channel - Hospital, Retail
Pharmacies and Other Distribution Channels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 118: India 16-Year Perspective for Cystic Fibrosis
Therapeutics by Distribution Channel - Percentage Breakdown of
Value Sales for Hospital, Retail Pharmacies and Other
Distribution Channels for the Years 2014, 2023 & 2030

SOUTH KOREA
Table 119: South Korea Recent Past, Current & Future Analysis
for Cystic Fibrosis Therapeutics by Treatment Method -
Medication, Devices and Other Treatment Methods - Independent

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06346124/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001